4因子固定剂量与4因子基于体重的剂量相比,用于新出现的华法林逆转的前列红素复合缩物:系统性审查和元分析
Mohammed Alrashed1,2,3, Norah Alabdulkarim1, Jana Alaskah1
1College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
Clinical and experimental emergency medicine
|January 14, 2025
概括
在紧急的华法林逆转中,可变剂量的4因子前素复合缩物 (PCC) 比固定的剂量更有效. 这两种策略都显示出类似的死亡率和血栓塞栓事件,但固定的剂量可能需要额外的管理.
科学领域:
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
- 基于证据的实践.
背景情况:
- 紧急的华法林逆转对于管理出血事件至关重要.
- 四因子前素复合缩物 (4-PCC) 是华法林逆转的关键药物.
- 4-PCC的剂量策略,固定的剂量与基于体重的剂量,需要进行比较评估.
研究的目的:
- 系统地审查和元分析固定的剂量与基于体重的4-PCC的疗效和安全性,以紧急扭转华法林.
- 为了比较关键的临床结果,包括INR逆转,静血疗效,血栓栓塞事件和死亡率.
主要方法:
- 一个全面的系统审查和随机临床试验和观察性研究的元分析.
- 在PubMed,Embase和Cochrane数据库中搜索到2023年10月.
- 包括十四项研究,比较了成年患者的固定剂量和可变剂量4-PCC.
主要成果:
- 4-PCC的可变剂量比固定的剂量更有效地实现了目标INR目标 (RR = 0.84,95% CI 0.80 - 0.89).
- 固定剂量4-PCC需要在26%的患者 (169/651) 进行额外的管理.
- 死亡率 (RR = 0.85,95% CI 0.70 - 1.03) 和血栓栓塞事件发生率在各组之间相似.
结论:
- 与固定的剂量相比,4-PCC的可变剂量在华法林逆转中达到目标INR方面优于固定的剂量.
- 这两种剂量策略在死亡率和血栓塞栓事件方面都显示出相似的安全性.
- 未来的研究应该优化4-PCC剂量,以平衡疗效,安全性和临床实用性.
相关概念视频
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.1K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.1K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
607
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
607
Hepatic Drug Clearance: Effect of Protein Binding
146
Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
146
Dosage Regimen: Fixed Dose
1.8K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.8K
Time Course of Drug Effect
1.9K
The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50...
1.9K
Compartment Models: Two-Compartment Model
5.2K
The two-compartment model divides the body into central and peripheral compartments to account for varying blood perfusion rates among organs and tissues, affecting drug distribution. The central compartment includes blood and highly perfused tissues with rapid drug distribution, while the peripheral compartment contains tissues with slower drug distribution. After a single IV bolus dose, the drug concentration is high in plasma and low in tissues. The drug distribution between compartments...
5.2K


